$ALIM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALIMERA SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALIMERA SCIENCES INC. Get notifications about new insider transactions in ALIMERA SCIENCES INC for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2018 | ALIM | ALIMERA SCIENCES I ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 1.14 | 4,000 | 4,560 | 6,928,000 | 6.9 M to 6.9 M (+0.06 %) |
| Feb 09 2018 | ALIM | ALIMERA SCIENCES I ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 1.16 | 8,000 | 9,280 | 6,924,000 | 6.9 M to 6.9 M (+0.12 %) |
| Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Option Exercise | A | 1.16 | 395,000 | 458,200 | 395,000 | |
| Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Grant | A | 0.00 | 124,100 | 0 | 199,161 | 75.1 K to 199.2 K (+165.33 %) |
| Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Option Exercise | A | 1.16 | 150,000 | 174,000 | 150,000 | |
| Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Grant | A | 0.00 | 56,400 | 0 | 165,988 | 109.6 K to 166 K (+51.47 %) |
| Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Option Exercise | A | 1.16 | 185,000 | 214,600 | 185,000 | |
| Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Grant | A | 0.00 | 61,100 | 0 | 231,734 | 170.6 K to 231.7 K (+35.81 %) |
| Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Option Exercise | A | 1.16 | 300,000 | 348,000 | 300,000 | |
| Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Grant | A | 0.00 | 83,800 | 0 | 161,770 | 78 K to 161.8 K (+107.48 %) |
| Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Option Exercise | A | 1.16 | 150,000 | 174,000 | 150,000 | |
| Jan 25 2018 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Grant | A | 0.00 | 56,400 | 0 | 56,400 | 0 to 56.4 K |
| Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Sell | S | 1.18 | 26,450 | 31,216 | 75,061 | 101.5 K to 75.1 K (-26.06 %) |
| Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Sell | S | 1.22 | 26,450 | 32,163 | 101,511 | 128 K to 101.5 K (-20.67 %) |
| Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Sell | S | 1.18 | 12,750 | 15,048 | 109,588 | 122.3 K to 109.6 K (-10.42 %) |
| Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Sell | S | 1.22 | 12,750 | 15,504 | 122,338 | 135.1 K to 122.3 K (-9.44 %) |
| Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 1.18 | 5,404 | 6,378 | 170,634 | 176 K to 170.6 K (-3.07 %) |
| Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 1.22 | 5,234 | 6,365 | 176,038 | 181.3 K to 176 K (-2.89 %) |
| Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Sell | S | 1.18 | 6,809 | 8,036 | 77,970 | 84.8 K to 78 K (-8.03 %) |
| Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Sell | S | 1.22 | 6,601 | 8,027 | 84,779 | 91.4 K to 84.8 K (-7.22 %) |
| Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Sell | S | 1.18 | 12,750 | 15,048 | 0 | 12.8 K to 0 (-100.00 %) |
| Jan 19 2018 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Sell | S | 1.22 | 12,750 | 15,504 | 12,750 | 25.5 K to 12.8 K (-50.00 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Sell | S | 1.23 | 12,750 | 15,695 | 135,088 | 147.8 K to 135.1 K (-8.62 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Sell | S | 1.24 | 12,750 | 15,779 | 147,838 | 160.6 K to 147.8 K (-7.94 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 1.23 | 5,739 | 7,065 | 181,272 | 187 K to 181.3 K (-3.07 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 1.24 | 5,750 | 7,116 | 187,011 | 192.8 K to 187 K (-2.98 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Sell | S | 1.23 | 12,750 | 15,695 | 25,500 | 38.3 K to 25.5 K (-33.33 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Sell | S | 1.24 | 12,750 | 15,779 | 38,250 | 51 K to 38.3 K (-25.00 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Sell | S | 1.23 | 26,450 | 32,560 | 127,961 | 154.4 K to 128 K (-17.13 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Sell | S | 1.24 | 26,450 | 32,735 | 154,411 | 180.9 K to 154.4 K (-14.62 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Sell | S | 1.23 | 7,239 | 8,911 | 91,380 | 98.6 K to 91.4 K (-7.34 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Sell | S | 1.24 | 7,255 | 8,979 | 98,619 | 105.9 K to 98.6 K (-6.85 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Sell | S | 1.23 | 12,750 | 15,695 | 25,500 | 38.3 K to 25.5 K (-33.33 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Sell | S | 1.24 | 12,750 | 15,779 | 38,250 | 51 K to 38.3 K (-25.00 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Sell | S | 1.23 | 26,450 | 32,560 | 127,961 | 154.4 K to 128 K (-17.13 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Sell | S | 1.24 | 26,450 | 32,735 | 154,411 | 180.9 K to 154.4 K (-14.62 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Sell | S | 1.23 | 7,239 | 8,911 | 91,380 | 98.6 K to 91.4 K (-7.34 %) |
| Jan 18 2018 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Sell | S | 1.24 | 7,255 | 8,979 | 98,619 | 105.9 K to 98.6 K (-6.85 %) |
| Jun 26 2017 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 1.37 | 40,000 | 54,800 | 40,000 | |
| Jun 23 2017 | ALIM | ALIMERA SCIENCES I ... | Brooks Mark J | Director | Option Exercise | A | 1.37 | 40,000 | 54,800 | 40,000 | |
| Jun 23 2017 | ALIM | ALIMERA SCIENCES I ... | Pizzo Peter J. III | Director | Option Exercise | A | 1.37 | 40,000 | 54,800 | 40,000 | |
| Jun 23 2017 | ALIM | ALIMERA SCIENCES I ... | Roberts Calvin W. | Director | Option Exercise | A | 1.37 | 40,000 | 54,800 | 40,000 | |
| Jun 23 2017 | ALIM | ALIMERA SCIENCES I ... | Kong Garheng | Director | Option Exercise | A | 1.37 | 40,000 | 54,800 | 40,000 | |
| Jun 23 2017 | ALIM | ALIMERA SCIENCES I ... | BRADLEY GLEN | Director | Option Exercise | A | 1.37 | 40,000 | 54,800 | 40,000 | |
| Jun 23 2017 | ALIM | ALIMERA SCIENCES I ... | Largent James R | Director | Option Exercise | A | 1.37 | 40,000 | 54,800 | 40,000 | |
| Mar 13 2017 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Sell | S | 1.39 | 21,172 | 29,429 | 180,861 | 202 K to 180.9 K (-10.48 %) |
| Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Option Exercise | A | 1.18 | 200,000 | 236,000 | 200,000 | |
| Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Grant | A | 0.00 | 56,200 | 0 | 192,761 | 136.6 K to 192.8 K (+41.15 %) |
| Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Option Exercise | A | 1.18 | 425,000 | 501,500 | 425,000 | |
| Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Grant | A | 0.00 | 105,800 | 0 | 202,033 | 96.2 K to 202 K (+109.94 %) |
| Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Option Exercise | A | 1.18 | 325,000 | 383,500 | 325,000 | |
| Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Grant | A | 0.00 | 70,900 | 0 | 105,874 | 35 K to 105.9 K (+202.72 %) |
| Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Option Exercise | A | 1.18 | 150,000 | 177,000 | 150,000 | |
| Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Grant | A | 0.00 | 51,000 | 0 | 160,588 | 109.6 K to 160.6 K (+46.54 %) |
| Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Option Exercise | A | 1.18 | 150,000 | 177,000 | 150,000 | |
| Jan 23 2017 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Grant | A | 0.00 | 51,000 | 0 | 51,000 | 0 to 51 K |
| Dec 14 2016 | ALIM | ALIMERA SCIENCES I ... | Roberts Calvin W. | Director | Sell | S | 1.11 | 30,000 | 33,300 | 65,820 | 95.8 K to 65.8 K (-31.31 %) |
| Dec 14 2016 | ALIM | ALIMERA SCIENCES I ... | Roberts Calvin W. | Director | Sell | S | 1.11 | 20,000 | 22,200 | 75,620 | 95.6 K to 75.6 K (-20.92 %) |
| Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Option Exercise | M | 1.33 | 55,147 | 73,346 | 0 | |
| Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Payment of Exercise | F | 1.50 | 48,898 | 73,347 | 96,233 | 145.1 K to 96.2 K (-33.69 %) |
| Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Buy | M | 1.33 | 55,147 | 73,346 | 145,131 | 90 K to 145.1 K (+61.29 %) |
| Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Option Exercise | M | 1.33 | 27,971 | 37,201 | 0 | |
| Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Payment of Exercise | F | 1.50 | 24,801 | 37,202 | 109,588 | 134.4 K to 109.6 K (-18.45 %) |
| Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Buy | M | 1.33 | 27,971 | 37,201 | 134,389 | 106.4 K to 134.4 K (+26.28 %) |
| Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Option Exercise | M | 1.33 | 36,177 | 48,115 | 0 | |
| Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Option Exercise | M | 1.33 | 8,031 | 10,681 | 0 | |
| Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Buy | M | 1.33 | 36,177 | 48,115 | 136,561 | 100.4 K to 136.6 K (+36.04 %) |
| Oct 13 2016 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Buy | M | 1.33 | 8,031 | 10,681 | 100,384 | 92.4 K to 100.4 K (+8.70 %) |
| Sep 16 2016 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Option Exercise | M | 1.33 | 51,471 | 68,456 | 0 | |
| Sep 16 2016 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Sell | S | 1.51 | 51,471 | 77,726 | 34,974 | 86.4 K to 35 K (-59.54 %) |
| Sep 16 2016 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Buy | M | 1.33 | 51,471 | 68,456 | 86,445 | 35 K to 86.4 K (+147.17 %) |
| Jun 27 2016 | ALIM | ALIMERA SCIENCES I ... | Pizzo Peter J. III | Director | Option Exercise | A | 1.49 | 20,000 | 29,800 | 20,000 | |
| Jun 27 2016 | ALIM | ALIMERA SCIENCES I ... | Largent James R | Director | Option Exercise | A | 1.49 | 20,000 | 29,800 | 20,000 | |
| Jun 27 2016 | ALIM | ALIMERA SCIENCES I ... | Roberts Calvin W. | Director | Option Exercise | A | 1.49 | 20,000 | 29,800 | 20,000 | |
| Jun 27 2016 | ALIM | ALIMERA SCIENCES I ... | BRADLEY GLEN | Director | Option Exercise | A | 1.49 | 20,000 | 29,800 | 20,000 | |
| Jun 27 2016 | ALIM | ALIMERA SCIENCES I ... | Kong Garheng | Director | Option Exercise | A | 1.49 | 20,000 | 29,800 | 20,000 | |
| Jun 27 2016 | ALIM | ALIMERA SCIENCES I ... | Halak Brian K | Director | Option Exercise | A | 1.49 | 20,000 | 29,800 | 20,000 | |
| Jun 24 2016 | ALIM | ALIMERA SCIENCES I ... | Brooks Mark J | Director | Option Exercise | A | 1.49 | 20,000 | 29,800 | 20,000 | |
| Apr 22 2016 | ALIM | ALIMERA SCIENCES I ... | BAVP, L.P. | 10% Owner | Sell | S | 5.15 | 700 | 3,605 | 3,998,718 | 4 M to 4 M (-0.02 %) |
| Apr 22 2016 | ALIM | ALIMERA SCIENCES I ... | BAVP, L.P. | 10% Owner | Sell | S | 4.15 | 3,300 | 13,695 | 3,999,418 | 4 M to 4 M (-0.08 %) |
| Apr 22 2016 | ALIM | ALIMERA SCIENCES I ... | BAVP, L.P. | 10% Owner | Sell | S | 3.35 | 20,703 | 69,355 | 4,002,718 | 4 M to 4 M (-0.51 %) |
| Apr 22 2016 | ALIM | ALIMERA SCIENCES I ... | BAVP, L.P. | 10% Owner | Sell | S | 2.54 | 453,870 | 1,152,830 | 4,023,421 | 4.5 M to 4 M (-10.14 %) |
| Apr 22 2016 | ALIM | ALIMERA SCIENCES I ... | BAVP, L.P. | 10% Owner | Sell | S | 2.02 | 100 | 202 | 4,477,291 | 4.5 M to 4.5 M (0.00 %) |
| Jan 06 2016 | ALIM | ALIMERA SCIENCES I ... | Ashman Philip | SVP, EU Managing Di ... | Option Exercise | A | 2.47 | 125,000 | 308,750 | 125,000 | |
| Jan 06 2016 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Option Exercise | A | 2.47 | 125,000 | 308,750 | 125,000 | |
| Jan 06 2016 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Option Exercise | A | 2.47 | 195,000 | 481,650 | 195,000 | |
| Jan 06 2016 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | President and CFO | Option Exercise | A | 2.47 | 275,000 | 679,250 | 275,000 | |
| Jan 06 2016 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | CEO | Option Exercise | A | 2.47 | 450,000 | 1,111,500 | 450,000 | |
| Dec 17 2015 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | COO and CFO | Option Exercise | M | 1.33 | 15,409 | 20,494 | 0 | |
| Dec 17 2015 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | COO and CFO | Option Exercise | M | 1.33 | 31,260 | 41,576 | 15,409 | |
| Dec 17 2015 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | COO and CFO | Sell | S | 2.30 | 15,409 | 35,399 | 34,974 | 50.4 K to 35 K (-30.58 %) |
| Dec 17 2015 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | COO and CFO | Buy | M | 1.33 | 15,409 | 20,494 | 50,383 | 35 K to 50.4 K (+44.06 %) |
| Dec 17 2015 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | COO and CFO | Sell | S | 2.32 | 31,260 | 72,520 | 34,974 | 66.2 K to 35 K (-47.20 %) |
| Dec 17 2015 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | COO and CFO | Buy | M | 1.33 | 31,260 | 41,576 | 66,234 | 35 K to 66.2 K (+89.38 %) |
| Dec 17 2015 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Option Exercise | M | 1.33 | 44,118 | 58,677 | 0 | |
| Dec 17 2015 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Buy | M | 1.33 | 44,118 | 58,677 | 92,353 | 48.2 K to 92.4 K (+91.46 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.04 | 27,530 | 83,774 | 728,718 | 701.2 K to 728.7 K (+3.93 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.04 | 27,529 | 83,771 | 4,760,408 | 4.7 M to 4.8 M (+0.58 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 68,294 | 204,848 | 701,188 | 632.9 K to 701.2 K (+10.79 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 68,294 | 204,848 | 4,732,879 | 4.7 M to 4.7 M (+1.46 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.01 | 40,301 | 121,169 | 632,894 | 592.6 K to 632.9 K (+6.80 %) |
| Dec 08 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.01 | 40,301 | 121,169 | 4,664,585 | 4.6 M to 4.7 M (+0.87 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 53,487 | 160,589 | 592,593 | 539.1 K to 592.6 K (+9.92 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 53,486 | 160,586 | 4,624,284 | 4.6 M to 4.6 M (+1.17 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.98 | 55,257 | 164,876 | 539,106 | 483.8 K to 539.1 K (+11.42 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.98 | 55,257 | 164,876 | 4,570,798 | 4.5 M to 4.6 M (+1.22 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.05 | 12,882 | 39,273 | 483,849 | 471 K to 483.8 K (+2.74 %) |
| Dec 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.05 | 12,883 | 39,276 | 4,515,541 | 4.5 M to 4.5 M (+0.29 %) |
| Nov 16 2015 | ALIM | ALIMERA SCIENCES I ... | Holland David | SVP of Sales and Ma ... | Grant | A | 2.56 | 2,500 | 6,396 | 106,418 | 103.9 K to 106.4 K (+2.41 %) |
| Nov 16 2015 | ALIM | ALIMERA SCIENCES I ... | Myers C. Daniel | President and CEO | Grant | A | 2.56 | 989 | 2,530 | 89,984 | 89 K to 90 K (+1.11 %) |
| Nov 10 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.98 | 36,625 | 109,241 | 470,967 | 434.3 K to 471 K (+8.43 %) |
| Nov 10 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.98 | 36,625 | 109,241 | 4,502,658 | 4.5 M to 4.5 M (+0.82 %) |
| Nov 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 8,271 | 24,813 | 434,342 | 426.1 K to 434.3 K (+1.94 %) |
| Nov 03 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 8,271 | 24,813 | 4,466,033 | 4.5 M to 4.5 M (+0.19 %) |
| Oct 29 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.99 | 13,165 | 39,363 | 426,071 | 412.9 K to 426.1 K (+3.19 %) |
| Oct 29 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.99 | 13,165 | 39,363 | 4,457,762 | 4.4 M to 4.5 M (+0.30 %) |
| Oct 29 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 16,506 | 49,518 | 412,906 | 396.4 K to 412.9 K (+4.16 %) |
| Oct 29 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 16,506 | 49,518 | 4,444,597 | 4.4 M to 4.4 M (+0.37 %) |
| Oct 26 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 17,117 | 51,361 | 396,400 | 379.3 K to 396.4 K (+4.51 %) |
| Oct 26 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 17,116 | 51,358 | 4,428,091 | 4.4 M to 4.4 M (+0.39 %) |
| Oct 26 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 12,090 | 36,270 | 379,283 | 367.2 K to 379.3 K (+3.29 %) |
| Oct 26 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 12,091 | 36,273 | 4,410,975 | 4.4 M to 4.4 M (+0.27 %) |
| Oct 26 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 975 | 2,925 | 367,193 | 366.2 K to 367.2 K (+0.27 %) |
| Oct 26 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 975 | 2,925 | 4,398,884 | 4.4 M to 4.4 M (+0.02 %) |
| Oct 21 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 80,342 | 241,042 | 366,218 | 285.9 K to 366.2 K (+28.10 %) |
| Oct 21 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 80,342 | 241,042 | 4,397,909 | 4.3 M to 4.4 M (+1.86 %) |
| Oct 21 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 50,065 | 150,060 | 285,876 | 235.8 K to 285.9 K (+21.23 %) |
| Oct 21 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 3.00 | 50,065 | 150,060 | 4,317,567 | 4.3 M to 4.3 M (+1.17 %) |
| Oct 21 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.92 | 64,613 | 188,825 | 235,811 | 171.2 K to 235.8 K (+37.74 %) |
| Oct 21 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.92 | 64,613 | 188,825 | 4,267,502 | 4.2 M to 4.3 M (+1.54 %) |
| Oct 16 2015 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | COO and CFO | Option Exercise | M | 2.04 | 13,625 | 27,795 | 0 | |
| Oct 16 2015 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | COO and CFO | Sell | S | 2.69 | 13,625 | 36,616 | 34,974 | 48.6 K to 35 K (-28.04 %) |
| Oct 16 2015 | ALIM | ALIMERA SCIENCES I ... | EISWIRTH RICHARD S JR | COO and CFO | Buy | M | 2.04 | 13,625 | 27,795 | 48,599 | 35 K to 48.6 K (+38.96 %) |
| Oct 09 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.53 | 71,540 | 180,710 | 171,198 | 99.7 K to 171.2 K (+71.79 %) |
| Oct 09 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.53 | 71,540 | 180,710 | 4,202,889 | 4.1 M to 4.2 M (+1.73 %) |
| Oct 09 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.50 | 19,817 | 49,543 | 99,658 | 79.8 K to 99.7 K (+24.82 %) |
| Oct 09 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.50 | 19,816 | 49,540 | 4,131,349 | 4.1 M to 4.1 M (+0.48 %) |
| Oct 09 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.30 | 69,536 | 159,724 | 79,841 | 10.3 K to 79.8 K (+674.78 %) |
| Oct 09 2015 | ALIM | ALIMERA SCIENCES I ... | Flynn James E | 10% Owner | Buy | P | 2.30 | 69,536 | 159,724 | 4,111,533 | 4 M to 4.1 M (+1.72 %) |
| Sep 08 2015 | ALIM | ALIMERA SCIENCES I ... | Roberts Calvin W. | Director | Buy | P | 3.00 | 200 | 600 | 2,350 | 2.2 K to 2.4 K (+9.30 %) |
| Sep 08 2015 | ALIM | ALIMERA SCIENCES I ... | Roberts Calvin W. | Director | Buy | P | 3.00 | 6,224 | 18,672 | 101,845 | 95.6 K to 101.8 K (+6.51 %) |
| Sep 01 2015 | ALIM | ALIMERA SCIENCES I ... | Roberts Calvin W. | Director | Buy | P | 3.00 | 2,150 | 6,450 | 2,150 | 0 to 2.2 K |
| Sep 01 2015 | ALIM | ALIMERA SCIENCES I ... | Roberts Calvin W. | Director | Buy | P | 3.00 | 6,389 | 19,167 | 6,389 | 0 to 6.4 K |
| Aug 21 2015 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 3.29 | 19,600 | 64,484 | 48,235 | 67.8 K to 48.2 K (-28.89 %) |
| Aug 21 2015 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 3.31 | 400 | 1,324 | 67,835 | 68.2 K to 67.8 K (-0.59 %) |
| Aug 19 2015 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 3.91 | 100 | 391 | 68,235 | 68.3 K to 68.2 K (-0.15 %) |
| Aug 19 2015 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 3.90 | 18,695 | 72,911 | 68,335 | 87 K to 68.3 K (-21.48 %) |
| Aug 19 2015 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 3.97 | 501 | 1,989 | 87,030 | 87.5 K to 87 K (-0.57 %) |
| Aug 19 2015 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 3.93 | 304 | 1,195 | 87,531 | 87.8 K to 87.5 K (-0.35 %) |
| Aug 19 2015 | ALIM | ALIMERA SCIENCES I ... | Green Kenneth | SVP & Chief Scienti ... | Sell | S | 3.92 | 400 | 1,568 | 87,835 | 88.2 K to 87.8 K (-0.45 %) |